Plant-derived epigenetic modulators for cancer treatment and prevention

Biotechnology Advances

Volumn 32, Issue 6, 2014, Pages 1123-1132

  Schnekenburger, Michael ^a   Dicato, Mario ^a   Diederich, Marc ^b  

^a LABORATOIRE DE BIOLOGIE MOLÉCULAIRE ET CELLULAIRE DU CANCER   (Luxembourg)

^b Seoul National University   (South Korea)

Author keywords

Cancer prevention; Cancer therapy; Cell death; Clinical trials; Epigenetics; Natural compounds; Proliferation

Indexed keywords

CELL DEATH; CELL PROLIFERATION; MACHINERY; PATHOLOGY;

CANCER PREVENTION; CANCER THERAPY; CLINICAL TRIAL; EPIGENETICS; NATURAL COMPOUNDS; PROLIFERATION;

DISEASES;

ANTINEOPLASTIC AGENT; PLANT EXTRACT;

ANIMAL; DRUG EFFECTS; GENETIC EPIGENESIS; HUMAN; MOUSE; NEOPLASMS; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; EPIGENESIS, GENETIC; HUMANS; MICE; NEOPLASMS; PLANT EXTRACTS;

EID: 84926262041     PISSN: 07349750     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biotechadv.2014.03.009     Document Type: Review

References (135)

1. Acharya A., Das I., Singh S., Saha T. Chemopreventive properties of indole-3-carbinol, diindolylmethane and other constituents of cardamom against carcinogenesis. Recent Pat Food Nutr Agric 2010, 2:166-177.
2. Agarwal S., Amin K.S., Jagadeesh S., Baishay G., Rao P.G., Barua N.C., et al. Mahanine restores RASSF1A expression by down-regulating DNMT1 and DNMT3B in prostate cancer cells. Mol Cancer 2013, 12:99.
3. Ahmad A., Sakr W.A., Rahman K.M. Novel targets for detection of cancer and their modulation by chemopreventive natural compounds. Front Biosci (Elite Ed) 2012, 4:410-425.
4. Aluyen J.K., Ton Q.N., Tran T., Yang A.E., Gottlieb H.B., Bellanger R.A. Resveratrol: potential as anticancer agent. J Diet Suppl 2012, 9:45-56.
5. Amin A., Gali-Muhtasib H., Ocker M., Schneider-Stock R. Overview of major classes of plant-derived anticancer drugs. Int J Biomed Sci 2009, 5:1-11.
6. Balasubramanian S., Adhikary G., Eckert R.L. The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival. Carcinogenesis 2010, 31:496-503.
7. Balasubramanyam K., Swaminathan V., Ranganathan A., Kundu T.K. Small molecule modulators of histone acetyltransferase p300. J Biol Chem 2003, 278:19134-19140.
8. Balasubramanyam K., Varier R.A., Altaf M., Swaminathan V., Siddappa N.B., Ranga U., et al. Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription. J Biol Chem 2004, 279:51163-51171.
9. Bannister A.J., Kouzarides T. Regulation of chromatin by histone modifications. Cell Res 2011, 21:381-395.
10. Batta K., Das C., Gadad S., Shandilya J., Kundu T.K. Reversible acetylation of non histone proteins: role in cellular function and disease. Subcell Biochem 2007, 41:193-212.
11. Beaver L.M., Yu T.W., Sokolowski E.I., Williams D.E., Dashwood R.H., Ho E. 3,3'-Diindolylmethane, but not indole-3-carbinol, inhibits histone deacetylase activity in prostate cancer cells. Toxicol Appl Pharmacol 2012, 263:345-351.
12. Berger A., Venturelli S., Kallnischkies M., Bocker A., Busch C., Weiland T., et al. Kaempferol, a new nutrition-derived pan-inhibitor of human histone deacetylases. J Nutr Biochem 2013, 24:977-985.
13. Boily G., He X.H., Pearce B., Jardine K., McBurney M.W. SirT1-null mice develop tumors at normal rates but are poorly protected by resveratrol. Oncogene 2009, 28:2882-2893.
14. Bontempo P., Mita L., Miceli M., Doto A., Nebbioso A., De Bellis F., et al. Feijoa sellowiana derived natural Flavone exerts anti-cancer action displaying HDAC inhibitory activities. Int J Biochem Cell Biol 2007, 39:1902-1914.
15. Bosviel R., Dumollard E., Dechelotte P., Bignon Y.J., Bernard-Gallon D. Can soy phytoestrogens decrease DNA methylation in BRCA1 and BRCA2 oncosuppressor genes in breast cancer?. OMICS 2012, 16:235-244.
16. Bosviel R., Durif J., Dechelotte P., Bignon Y.J., Bernard-Gallon D. Epigenetic modulation of BRCA1 and BRCA2 gene expression by equol in breast cancer cell lines. Br J Nutr 2012, 108:1187-1193.
17. Cha T.L., Chuang M.J., Tang S.H., Wu S.T., Sun K.H., Chen T.T., et al. Emodin modulates epigenetic modifications and suppresses bladder carcinoma cell growth. Mol Carcinog 2013.
18. Charlet J., Schnekenburger M., Brown K.W., Diederich M. DNA demethylation increases sensitivity of neuroblastoma cells to chemotherapeutic drugs. Biochem Pharmacol 2012, 83:858-865.
19. Chehl N., Chipitsyna G., Gong Q., Yeo C.J., Arafat H.A. Anti-inflammatory effects of the Nigella sativa seed extract, thymoquinone, in pancreatic cancer cells. HPB 2009, 11:373-381.
20. Chen Y., Shu W., Chen W., Wu Q., Liu H., Cui G. Curcumin, both histone deacetylase and p300/CBP-specific inhibitor, represses the activity of nuclear factor kappa B and Notch 1 in Raji cells. Basic Clin Pharmacol Toxicol 2007, 101:427-433.
21. Chen I.H., Lu M.C., Du Y.C., Yen M.H., Wu C.C., Chen Y.H., et al. Cytotoxic triterpenoids from the stems of Microtropis japonica. J Nat Prod 2009, 72:1231-1236.
22. Choi K.C., Jung M.G., Lee Y.H., Yoon J.C., Kwon S.H., Kang H.B., et al. Epigallocatechin-3-gallate, a histone acetyltransferase inhibitor, inhibits EBV-induced B lymphocyte transformation via suppression of RelA acetylation. Cancer Res 2009, 69:583-592.
23. Choi K.C., Lee Y.H., Jung M.G., Kwon S.H., Kim M.J., Jun W.J., et al. Gallic acid suppresses lipopolysaccharide-induced nuclear factor-kappaB signaling by preventing RelA acetylation in A549 lung cancer cells. Mol Cancer Res 2009, 7:2011-2021.
24. Chung I.M., Kim M.Y., Park W.H., Moon H.I. Histone deacetylase inhibitors from the rhizomes of Zingiber zerumbet. Pharmazie 2008, 63:774-776.
25. Cosio B.G., Tsaprouni L., Ito K., Jazrawi E., Adcock I.M., Barnes P.J. Theophylline restores histone deacetylase activity and steroid responses in COPD macrophages. J Exp Med 2004, 200:689-695.
26. Cui Y., Lu C., Kang A., Liu L., Tan S., Sun D., et al. Nordihydroguaiaretic acid restores expression of silenced E-cadherin gene in human breast cancer cell lines and xenografts. Anticancer Drugs 2008, 19:487-494.
27. Cui Y., Lu C., Liu L., Sun D., Yao N., Tan S., et al. Reactivation of methylation-silenced tumor suppressor gene p16INK4a by nordihydroguaiaretic acid and its implication in G1 cell cycle arrest. Life Sci 2008, 82:247-255.
28. Cui W., Gu F., Hu K.Q. Effects and mechanisms of silibinin on human hepatocellular carcinoma xenografts in nude mice. World J Gastroenterol 2009, 15:1943-1950.
29. Dal Piaz F., Tosco A., Eletto D., Piccinelli A.L., Moltedo O., Franceschelli S., et al. The identification of a novel natural activator of p300 histone acetyltranferase provides new insights into the modulation mechanism of this enzyme. Chembiochem 2010, 11:818-827.
30. Dalvoy Vasudevarao M., Dhanasekaran K., Selvi R.B., Kundu T.K. Inhibition of acetyltransferase alters different histone modifications: probed by small molecule inhibitor plumbagin. J Biochem 2012, 152:453-462.
31. Davie J.R. Inhibition of histone deacetylase activity by butyrate. J Nutr 2003, 133:2485S-2493S.
32. Davis C.D., Uthus E.O., Finley J.W. Dietary selenium and arsenic affect DNA methylation in vitro in Caco-2 cells and in vivo in rat liver and colon. J Nutr 2000, 130:2903-2909.
33. Druesne N., Pagniez A., Mayeur C., Thomas M., Cherbuy C., Duee P.H., et al. Diallyl disulfide (DADS) increases histone acetylation and p21(waf1/cip1) expression in human colon tumor cell lines. Carcinogenesis 2004, 25:1227-1236.
34. Duvoix A., Morceau F., Delhalle S., Schmitz M., Schnekenburger M., Galteau M.M., et al. Induction of apoptosis by curcumin: mediation by glutathione S-transferase P1-1 inhibition. Biochem Pharmacol 2003, 66:1475-1483.
35. Duvoix A., Morceau F., Schnekenburger M., Delhalle S., Galteau M.M., Dicato M., et al. Curcumin-induced cell death in two leukemia cell lines: K562 and Jurkat. Ann N Y Acad Sci 2003, 1010:389-392.
36. Duvoix A., Schmitz M., Schnekenburger M., Dicato M., Morceau F., Galteau M.M., et al. Transcriptional regulation of glutathione S-transferase P1-1 in human leukemia. Biofactors 2003, 17:131-138.
37. Duvoix A., Blasius R., Delhalle S., Schnekenburger M., Morceau F., Henry E., et al. Chemopreventive and therapeutic effects of curcumin. Cancer Lett 2005, 223:181-190.
38. Esteller M. Epigenetic gene silencing in cancer: the DNA hypermethylome. Hum Mol Genet 2007, 16. [Spec No 1:R50-9].
39. Fang M.Z., Wang Y., Ai N., Hou Z., Sun Y., Lu H., et al. Tea polyphenol (-)-epigallocatechin-3-gallate inhibits DNA methyltransferase and reactivates methylation-silenced genes in cancer cell lines. Cancer Res 2003, 63:7563-7570.
40. Fang M.Z., Chen D., Sun Y., Jin Z., Christman J.K., Yang C.S. Reversal of hypermethylation and reactivation of p16INK4a, RARbeta, and MGMT genes by genistein and other isoflavones from soy. Clin Cancer Res 2005, 11:7033-7041.
41. Fang M.Z., Jin Z., Wang Y., Liao J., Yang G.Y., Wang L.D., et al. Promoter hypermethylation and inactivation of O(6)-methylguanine-DNA methyltransferase in esophageal squamous cell carcinomas and its reactivation in cell lines. Int J Oncol 2005, 26:615-622.
42. Fang M., Chen D., Yang C.S. Dietary polyphenols may affect DNA methylation. J Nutr 2007, 137:223S-228S.
43. Farghali H., Kutinova Canova N., Lekic N. Resveratrol and related compounds as antioxidants with an allosteric mechanism of action in epigenetic drug targets. Physiol Res 2013, 62:1-13.
44. Fiala E.S., Staretz M.E., Pandya G.A., El-Bayoumy K., Hamilton S.R. Inhibition of DNA cytosine methyltransferase by chemopreventive selenium compounds, determined by an improved assay for DNA cytosine methyltransferase and DNA cytosine methylation. Carcinogenesis 1998, 19:597-604.
45. Florean C., Schnekenburger M., Grandjenette C., Dicato M., Diederich M. Epigenomics of leukemia: from mechanisms to therapeutic applications. Epigenomics 2011, 3:581-609.
46. Folmer F., Orlikova B., Schnekenburger M., Dicato M., Diederich M. Naturally occurring regulators of histone acetylation/deacetylation. Curr Nutr Food Sci 2010, 6:78-99.
47. Gerhauser C. Cancer chemoprevention and nutriepigenetics: state of the art and future challenges. Top Curr Chem 2013, 329:73-132.
48. Ghoshal K., Bai S. DNA methyltransferases as targets for cancer therapy. Drugs Today (Barc) 2007, 43:395-422.
49. Gopal Y.N., Arora T.S., Van Dyke M.W. Parthenolide specifically depletes histone deacetylase 1 protein and induces cell death through ataxia telangiectasia mutated. Chem Biol 2007, 14:813-823.
50. Gottlicher M., Minucci S., Zhu P., Kramer O.H., Schimpf A., Giavara S., et al. Valproic acid defines a novel class of HDAC inhibitors inducing differentiation of transformed cells. EMBO J 2001, 20:6969-6978.
51. Gupta S.C., Kim J.H., Prasad S., Aggarwal B.B. Regulation of survival, proliferation, invasion, angiogenesis, and metastasis of tumor cells through modulation of inflammatory pathways by nutraceuticals. Cancer Metastasis Rev 2010, 29:405-434.
52. Ho E., Clarke J.D., Dashwood R.H. Dietary sulforaphane, a histone deacetylase inhibitor for cancer prevention. J Nutr 2009, 139:2393-2396.
53. Howitz K.T., Bitterman K.J., Cohen H.Y., Lamming D.W., Lavu S., Wood J.G., et al. Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan. Nature 2003, 425:191-196.
54. Hsu A., Wong C.P., Yu Z., Williams D.E., Dashwood R.H., Ho E. Promoter de-methylation of cyclin D2 by sulforaphane in prostate cancer cells. Clin Epigenetics 2011, 3:3.
55. Hua W.F., Fu Y.S., Liao Y.J., Xia W.J., Chen Y.C., Zeng Y.X., et al. Curcumin induces down-regulation of EZH2 expression through the MAPK pathway in MDA-MB-435 human breast cancer cells. Eur J Pharmacol 2010, 637:16-21.
56. Huang J., Plass C., Gerhauser C. Cancer chemoprevention by targeting the epigenome. Curr Drug Targets 2011, 12:1925-1956.
57. Jagadeesh S., Sinha S., Pal B.C., Bhattacharya S., Banerjee P.P. Mahanine reverses an epigenetically silenced tumor suppressor gene RASSF1A in human prostate cancer cells. Biochem Biophys Res Commun 2007, 362:212-217.
58. Jones P.A. Functions of DNA methylation: islands, start sites, gene bodies and beyond. Nat Rev Genet 2012, 13:484-492.
59. Kang J., Chen J., Shi Y., Jia J., Zhang Y. Curcumin-induced histone hypoacetylation: the role of reactive oxygen species. Biochem Pharmacol 2005, 69:1205-1213.
60. Karius T., Schnekenburger M., Ghelfi J., Walter J., Dicato M., Diederich M. Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines. Biochem Pharmacol 2011, 81:1329-1342.
61. Karius T., Schnekenburger M., Dicato M., Diederich M. MicroRNAs in cancer management and their modulation by dietary agents. Biochem Pharmacol 2012, 83:1591-1601.
62. Kauntz H., Bousserouel S., Gosse F., Raul F. Epigenetic effects of the natural flavonolignan silibinin on colon adenocarcinoma cells and their derived metastatic cells. Oncol Lett 2013, 5:1273-1277.
63. Khan N., Mukhtar H. Cancer and metastasis: prevention and treatment by green tea. Cancer Metastasis Rev 2010, 29:435-445.
64. Khor T.O., Huang Y., Wu T.Y., Shu L., Lee J., Kong A.N. Pharmacodynamics of curcumin as DNA hypomethylation agent in restoring the expression of Nrf2 via promoter CpGs demethylation. Biochem Pharmacol 2011, 82:1073-1078.
65. Kikuno N., Shiina H., Urakami S., Kawamoto K., Hirata H., Tanaka Y., et al. Genistein mediated histone acetylation and demethylation activates tumor suppressor genes in prostate cancer cells. Int J Cancer 2008, 123:552-560.
66. Kim B., Kim S.H., Jeong S.J., Sohn E.J., Jung J.H., Lee M.H., et al. Brazilin induces apoptosis and G2/M arrest via inactivation of histone deacetylase in multiple myeloma U266 cells. J Agric Food Chem 2012, 60:9882-9889.
67. King-Batoon A., Leszczynska J.M., Klein C.B. Modulation of gene methylation by genistein or lycopene in breast cancer cells. Environ Mol Mutagen 2008, 49:36-45.
68. Kramer O.H., Zhu P., Ostendorff H.P., Golebiewski M., Tiefenbach J., Peters M.A., et al. The histone deacetylase inhibitor valproic acid selectively induces proteasomal degradation of HDAC2. EMBO J 2003, 22:3411-3420.
69. Kulis M., Esteller M. DNA methylation and cancer. Adv Genet 2010, 70:27-56.
70. Lea M.A., Rasheed M., Randolph V.M., Khan F., Shareef A., desBordes C. Induction of histone acetylation and inhibition of growth of mouse erythroleukemia cells by S-allylmercaptocysteine. Nutr Cancer 2002, 43:90-102.
71. Leder A., Leder P. Butyric acid, a potent inducer of erythroid differentiation in cultured erythroleukemic cells. Cell 1975, 5:319-322.
72. Lee W.J., Zhu B.T. Inhibition of DNA methylation by caffeic acid and chlorogenic acid, two common catechol-containing coffee polyphenols. Carcinogenesis 2006, 27:269-277.
73. Lee B.H., Yegnasubramanian S., Lin X., Nelson W.G. Procainamide is a specific inhibitor of DNA methyltransferase 1. J Biol Chem 2005, 280:40749-40756.
74. Lee W.J., Shim J.Y., Zhu B.T. Mechanisms for the inhibition of DNA methyltransferases by tea catechins and bioflavonoids. Mol Pharmacol 2005, 68:1018-1030.
75. Li Y., Xiu-wu B., Shu-hui Z., et al. Arbitrarily primed PCR analysis the genomic methylation pattern in glioma cell induced by NDGA. Teratog Carcinog Mutagen 2004, 16:81-82.
76. Li Y., Li X., Guo B. Chemopreventive agent 3,3'-diindolylmethane selectively induces proteasomal degradation of class I histone deacetylases. Cancer Res 2010, 70:646-654.
77. Lin Y.H., Lee C.C., Chang F.R., Chang W.H., Wu Y.C., Chang J.G. 16-Hydroxycleroda-3,13-dien-15,16-olide regulates the expression of histone-modifying enzymes PRC2 complex and induces apoptosis in CML K562 cells. Life Sci 2011, 89:886-895.
78. Link A., Balaguer F., Goel A. Cancer chemoprevention by dietary polyphenols: promising role for epigenetics. Biochem Pharmacol 2010, 80:1771-1792.
79. Liu H.L., Chen Y., Cui G.H., Zhou J.F. Curcumin, a potent anti-tumor reagent, is a novel histone deacetylase inhibitor regulating B-NHL cell line Raji proliferation. Acta Pharmacol Sin 2005, 26:603-609.
80. Liu Z., Liu S., Xie Z., Pavlovicz R.E., Wu J., Chen P., et al. Modulation of DNA methylation by a sesquiterpene lactone parthenolide. J Pharmacol Exp Ther 2009, 329:505-514.
81. Liu Z., Xie Z., Jones W., Pavlovicz R.E., Liu S., Yu J., et al. Curcumin is a potent DNA hypomethylation agent. Bioorg Med Chem Lett 2009, 19:706-709.
82. Lu Q., Lin X., Feng J., Zhao X., Gallagher R., Lee M.Y., et al. Phenylhexyl isothiocyanate has dual function as histone deacetylase inhibitor and hypomethylating agent and can inhibit myeloma cell growth by targeting critical pathways. J Hematol Oncol 2008, 1:6.
83. Lu J.M., Nurko J., Weakley S.M., Jiang J., Kougias P., Lin P.H., et al. Molecular mechanisms and clinical applications of nordihydroguaiaretic acid (NDGA) and its derivatives: an update. Med Sci Monit 2010, 16:RA93-RA100.
84. Majid S., Kikuno N., Nelles J., Noonan E., Tanaka Y., Kawamoto K., et al. Genistein induces the p21WAF1/CIP1 and p16INK4a tumor suppressor genes in prostate cancer cells by epigenetic mechanisms involving active chromatin modification. Cancer Res 2008, 68:2736-2744.
85. Majid S., Dar A.A., Ahmad A.E., Hirata H., Kawakami K., Shahryari V., et al. BTG3 tumor suppressor gene promoter demethylation, histone modification and cell cycle arrest by genistein in renal cancer. Carcinogenesis 2009, 30:662-670.
86. Majid S., Dar A.A., Shahryari V., Hirata H., Ahmad A., Saini S., et al. Genistein reverses hypermethylation and induces active histone modifications in tumor suppressor gene B-Cell translocation gene 3 in prostate cancer. Cancer 2010, 116:66-76.
87. Marcu M.G., Jung Y.J., Lee S., Chung E.J., Lee M.J., Trepel J., et al. Curcumin is an inhibitor of p300 histone acetylatransferase. Med Chem 2006, 2:169-174.
88. Murakami A., Ashida H., Terao J. Multitargeted cancer prevention by quercetin. Cancer Lett 2008, 269:315-325.
89. Myzak M.C., Dashwood R.H. Histone deacetylases as targets for dietary cancer preventive agents: lessons learned with butyrate, diallyl disulfide, and sulforaphane. Curr Drug Targets 2006, 7:443-452.
90. Myzak M.C., Karplus P.A., Chung F.L., Dashwood R.H. A novel mechanism of chemoprotection by sulforaphane: inhibition of histone deacetylase. Cancer Res 2004, 64:5767-5774.
91. Myzak M.C., Tong P., Dashwood W.M., Dashwood R.H., Ho E. Sulforaphane retards the growth of human PC-3 xenografts and inhibits HDAC activity in human subjects. Exp Biol Med (Maywood) 2007, 232:227-234.
92. Nian H., Delage B., Pinto J.T., Dashwood R.H. Allyl mercaptan, a garlic-derived organosulfur compound, inhibits histone deacetylase and enhances Sp3 binding on the P21WAF1 promoter. Carcinogenesis 2008, 29:1816-1824.
93. Oh W.K., Cho K.B., Hien T.T., Kim T.H., Kim H.S., Dao T.T., et al. Amurensin G, a potent natural SIRT1 inhibitor, rescues doxorubicin responsiveness via down-regulation of multidrug resistance 1. Mol Pharmacol 2010, 78:855-864.
94. Olaharski A.J., Rine J., Marshall B.L., Babiarz J., Zhang L., Verdin E., et al. The flavoring agent dihydrocoumarin reverses epigenetic silencing and inhibits sirtuin deacetylases. PLoS Genet 2005, 1:e77.
95. Orlikova B., Schnekenburger M., Zloh M., Golais F., Diederich M., Tasdemir D. Natural chalcones as dual inhibitors of HDACs and NF-kappaB. Oncol Rep 2012, 28:797-805.
96. Pacholec M., Bleasdale J.E., Chrunyk B., Cunningham D., Flynn D., Garofalo R.S., et al. SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J Biol Chem 2010, 285:8340-8351.
97. Padhye S., Ahmad A., Oswal N., Sarkar F.H. Emerging role of Garcinol, the antioxidant chalcone from Garcinia indica Choisy and its synthetic analogs. J Hematol Oncol 2009, 2:38.
98. Paluszczak J., Krajka-Kuzniak V., Baer-Dubowska W. The effect of dietary polyphenols on the epigenetic regulation of gene expression in MCF7 breast cancer cells. Toxicol Lett 2010, 192:119-125.
99. Pandey M., Shukla S., Gupta S. Promoter demethylation and chromatin remodeling by green tea polyphenols leads to re-expression of GSTP1 in human prostate cancer cells. Int J Cancer 2010, 126:2520-2533.
100. Pandey M., Kaur P., Shukla S., Abbas A., Fu P., Gupta S. Plant flavone apigenin inhibits HDAC and remodels chromatin to induce growth arrest and apoptosis in human prostate cancer cells: in vitro and in vivo study. Mol Carcinog 2012, 51:952-962.
101. Rajavelu A., Tulyasheva Z., Jaiswal R., Jeltsch A., Kuhnert N. The inhibition of the mammalian DNA methyltransferase 3a (Dnmt3a) by dietary black tea and coffee polyphenols. BMC Biochem 2011, 12:16.
102. Ravindra K.C., Selvi B.R., Arif M., Reddy B.A., Thanuja G.R., Agrawal S., et al. Inhibition of lysine acetyltransferase KAT3B/p300 activity by a naturally occurring hydroxynaphthoquinone, plumbagin. J Biol Chem 2009, 284:24453-24464.
103. Rietjens I.M., Sotoca A.M., Vervoort J., Louisse J. Mechanisms underlying the dualistic mode of action of major soy isoflavones in relation to cell proliferation and cancer risks. Mol Nutr Food Res 2013, 57:100-113.
104. Rogan E.G. The natural chemopreventive compound indole-3-carbinol: state of the science. In Vivo 2006, 20:221-228.
105. Ruotolo R., Tosi F., Vernarecci S., Ballario P., Mai A., Filetici P., et al. Chemogenomic profiling of the cellular effects associated with histone H3 acetylation impairment by a quinoline-derived compound. Genomics 2010, 96:272-280.
106. Scharlau D., Borowicki A., Habermann N., Hofmann T., Klenow S., Miene C., et al. Mechanisms of primary cancer prevention by butyrate and other products formed during gut flora-mediated fermentation of dietary fibre. Mutat Res 2009, 682:39-53.
107. Schneider-Stock R., Ghantous A., Bajbouj K., Saikali M., Darwiche N. Epigenetic mechanisms of plant-derived anticancer drugs. Front Biosci 2012, 17:129-173.
108. Schnekenburger M., Diederich M. Conference Scene: omic technologies in human disease: extending the network of epigenetic control. Epigenomics 2011, 3:539-541.
109. Schnekenburger M., Diederich M. Epigenetics offer new horizons for colorectal cancer prevention. Curr Colorectal Cancer Rep 2012, 8:66-81.
110. Schnekenburger M., Morceau F., Henry E., Blasius R., Dicato M., Trentesaux C., et al. Transcriptional and post-transcriptional regulation of glutathione S-transferase P1 expression during butyric acid-induced differentiation of K562 cells. Leuk Res 2006, 30:561-568.
111. Schnekenburger M., Grandjenette C., Ghelfi J., Karius T., Foliguet B., Dicato M., et al. Sustained exposure to the DNA demethylating agent, 2'-deoxy-5-azacytidine, leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation, senescence, and autophagy. Biochem Pharmacol 2011, 81:364-378.
112. Scott E., Steward W.P., Gescher A.J., Brown K. Resveratrol in human cancer chemoprevention-choosing the 'right' dose. Mol Nutr Food Res 2012, 56:7-13.
113. Sealy L., Chalkley R. The effect of sodium butyrate on histone modification. Cell 1978, 14:115-121.
114. Seidel C., Florean C., Schnekenburger M., Dicato M., Diederich M. Chromatin-modifying agents in anti-cancer therapy. Biochimie 2012, 94:2264-2279.
115. Seidel C., Schnekenburger M., Dicato M., Diederich M. Histone deacetylase modulators provided by Mother Nature. Genes Nutr 2012, 7:357-367.
116. Seidel C., Schnekenburger M., Dicato M., Diederich M. Antiproliferative and proapoptotic activities of 4-hydroxybenzoic acid-based inhibitors of histone deacetylases. Cancer Lett 2014, 343:134-146.
117. Selvi B.R., Pradhan S.K., Shandilya J., Das C., Sailaja B.S., Shankar G.N., et al. Sanguinarine interacts with chromatin, modulates epigenetic modifications, and transcription in the context of chromatin. Chem Biol 2009, 16:203-216.
118. Seong A.R., Yoo J.Y., Choi K., Lee M.H., Lee Y.H., Lee J., et al. Delphinidin, a specific inhibitor of histone acetyltransferase, suppresses inflammatory signaling via prevention of NF-kappaB acetylation in fibroblast-like synoviocyte MH7A cells. Biochem Biophys Res Commun 2011, 410:581-586.
119. Shirakami Y., Shimizu M., Moriwaki H. Cancer chemoprevention with green tea catechins: from bench to bed. Curr Drug Targets 2012, 13:1842-1857.
120. Shu L., Khor T.O., Lee J.H., Boyanapalli S.S., Huang Y., Wu T.Y., et al. Epigenetic CpG demethylation of the promoter and reactivation of the expression of Neurog1 by curcumin in prostate LNCaP cells. AAPS J 2011, 13:606-614.
121. Son I.H., Chung I.M., Lee S.I., Yang H.D., Moon H.I. Pomiferin, histone deacetylase inhibitor isolated from the fruits of Maclura pomifera. Bioorg Med Chem Lett 2007, 17:4753-4755.
122. Spurling C.C., Suhl J.A., Boucher N., Nelson C.E., Rosenberg D.W., Giardina C. The short chain fatty acid butyrate induces promoter demethylation and reactivation of RARbeta2 in colon cancer cells. Nutr Cancer 2008, 60:692-702.
123. Stefanska B., Rudnicka K., Bednarek A., Fabianowska-Majewska K. Hypomethylation and induction of retinoic acid receptor beta 2 by concurrent action of adenosine analogues and natural compounds in breast cancer cells. Eur J Pharmacol 2010, 638:47-53.
124. Stefanska B., Salame P., Bednarek A., Fabianowska-Majewska K. Comparative effects of retinoic acid, vitamin D and resveratrol alone and in combination with adenosine analogues on methylation and expression of phosphatase and tensin homologue tumour suppressor gene in breast cancer cells. Br J Nutr 2012, 107:781-790.
125. Supic G., Jagodic M., Magic Z. Epigenetics: a new link between nutrition and cancer. Nutr Cancer 2013, 65:781-792.
126. Tan S., Wang C., Lu C., Zhao B., Cui Y., Shi X., et al. Quercetin is able to demethylate the p16INK4a gene promoter. Chemotherapy 2009, 55:6-10.
127. Teiten M.H., Dicato M., Diederich M. Curcumin as a regulator of epigenetic events. Mol Nutr Food Res 2013, 57:1619-1629.
128. Vanden Berghe W. Epigenetic impact of dietary polyphenols in cancer chemoprevention: lifelong remodeling of our epigenomes. Pharmacol Res 2012, 65:565-576.
129. Wang L.G., Beklemisheva A., Liu X.M., Ferrari A.C., Feng J., Chiao J.W. Dual action on promoter demethylation and chromatin by an isothiocyanate restored GSTP1 silenced in prostate cancer. Mol Carcinog 2007, 46:24-31.
130. Wang L.G., Liu X.M., Fang Y., Dai W., Chiao F.B., Puccio G.M., et al. De-repression of the p21 promoter in prostate cancer cells by an isothiocyanate via inhibition of HDACs and c-Myc. Int J Oncol 2008, 33:375-380.
131. Wood J.G., Rogina B., Lavu S., Howitz K., Helfand S.L., Tatar M., et al. Sirtuin activators mimic caloric restriction and delay ageing in metazoans. Nature 2004, 430:686-689.
132. Xiong S.D., Yu K., Liu X.H., Yin L.H., Kirschenbaum A., Yao S., et al. Ribosome-inactivating proteins isolated from dietary bitter melon induce apoptosis and inhibit histone deacetylase-1 selectively in premalignant and malignant prostate cancer cells. Int J Cancer 2009, 125:774-782.
133. Yeung F., Hoberg J.E., Ramsey C.S., Keller M.D., Jones D.R., Frye R.A., et al. Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J 2004, 23:2369-2380.
134. Zhang X., Wen H., Shi X. Lysine methylation: beyond histones. Acta Biochim Biophys Sin 2012, 44:14-27.
135. Zhao F., Chen Y., Li R., Liu Y., Wen L., Zhang C. Triptolide alters histone H3K9 and H3K27 methylation state and induces G0/G1 arrest and caspase-dependent apoptosis in multiple myeloma in vitro. Toxicology 2010, 267:70-79.